Al-Dujaili AH, Mousa RF, Al-Hakeim HK, Maes M (2021) High mobility group protein 1 and dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: associations with interleukin-6, symptom domains, and neurocognitive impairments. Schizophr Bull 47:530–541

Article  PubMed  Google Scholar 

Assadiasl S, Rajabinejad M, Soleimanifar N, Makiyan F, Azizi E, Rezaiemanesh A, Nicknam MH (2023) MicroRNAs-mediated regulation pathways in rheumatic diseases. Inflammopharmacology 31:129–144

Article  CAS  PubMed  Google Scholar 

Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O (2009) Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet Part B: Neuropsychiatric Genet 150B:56–60

Article  CAS  Google Scholar 

Blackman G, Oloyede E, Horowitz M, Harland R, Taylor D, MacCabe J, McGuire P (2021) Reducing the risk of withdrawal symptoms and relapse following Clozapine Discontinuation—Is it feasible to develop evidence-based guidelines? Schizophr Bull 48:176–189

Article  PubMed Central  Google Scholar 

Boerrigter D, Weickert TW, Lenroot R, O’Donnell M, Galletly C, Liu D, Burgess M, Cadiz R, Jacomb I, Catts VS, Fillman SG, Weickert CS (2017) Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. J Neuroinflammation 14:188

Article  PubMed  PubMed Central  Google Scholar 

Bosnjak Kuharic D, Kekin I, Hew J, Rojnic Kuzman M, Puljak L (2019) Interventions for prodromal stage of psychosis. Cochrane Database of Systematic Reviews

Book  Google Scholar 

Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr (1998) Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 155:751–760

Article  CAS  PubMed  Google Scholar 

Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B (2001) Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 158:518–526

Article  CAS  PubMed  Google Scholar 

Chen ML, Tsai TC, Lin YY, Tsai YM, Wang LK, Lee MC, Tsai FM (2011) Antipsychotic drugs suppress the AKT/NF-κB pathway and regulate the differentiation of T-cell subsets. Immunol Lett 140:81–91

Article  CAS  PubMed  Google Scholar 

Chen ML, Tsai TC, Wang LK, Lin YY, Tsai YM, Lee MC, Tsai FM (2012) Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-γ production in peripheral blood mononuclear cells. Immunopharmacol Immunotoxicol 34:686–694

Article  CAS  PubMed  Google Scholar 

Chen ML, Wu S, Tsai TC, Wang LK, Tsai FM (2013) Regulation of macrophage immune responses by antipsychotic drugs. Immunopharmacol Immunotoxicol 35:573–580

Article  CAS  PubMed  Google Scholar 

Chouinard G, Jones BD, Annable L (1978) Neuroleptic-induced supersensitivity psychosis. The American journal of psychiatry

Google Scholar 

Correll CU, Howes OD (2021) Treatment-resistant Schizophrenia: definition, predictors, and Therapy options. J Clin Psychiatry 82:MY20096AH1C

Cotel MC, Lenartowicz EM, Natesan S, Modo MM, Cooper JD, Williams SC, Kapur S, Vernon AC (2015) Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. Eur Neuropsychopharmacol 25:2098–2107

Article  CAS  PubMed  Google Scholar 

Dada C (2020) How clozapine patients can be monitored safely and effectively. Evaluation 14:34

Google Scholar 

Dameshek W (1930) White blood cells in dementia praecox and dementia paralytica. Arch Neurol Psychiatry 24:855

Google Scholar 

de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S (2014) Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res 154:23–29

Article  PubMed  Google Scholar 

Dell’Osso L, Bonelli C, Nardi B, Giovannoni F, Pronestì C, Cremone IM, Amatori G, Pini S, Carpita B (2024) Rethinking clozapine: lights and shadows of a Revolutionary Drug. Brain Sci 14:103

Article  PubMed  PubMed Central  Google Scholar 

Dodd S, Maes M, Anderson G, Dean OM, Moylan S, Berk M (2013) Putative neuroprotective agents in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 42:135–145

Article  CAS  PubMed  Google Scholar 

Dong Y, Zhu M, Li Y, Liu N, Wang X, Yang B, Li S, Li Z (2024) Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome. Schizophrenia (Heidelb) 10:47

Article  PubMed  Google Scholar 

Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen Lvd, Beumer W, Versnel MA, Drexhage HA (2010) The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 10:59–76

Article  CAS  PubMed  Google Scholar 

Eftekharian MM, Omrani MD, Arsang-Jang S, Taheri M, Ghafouri-Fard S (2019) Serum cytokine profile in schizophrenic patients. Hum Antib 27:23–29

Article  CAS  Google Scholar 

Essali A, Al-Haj Haasan N, Li C, Rathbone J (2009) Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database Syst Rev 2009: Cd000059

Fang X, Yu L, Wang D, Chen Y, Wang Y, Wu Z, Liu R, Ren J, Tang W, Zhang C (2020) Association between SIRT1, Cytokines, and metabolic syndrome in Schizophrenia patients with olanzapine or Clozapine Monotherapy. Front Psychiatry 11:602121

Article  PubMed  PubMed Central  Google Scholar 

Feigenson KA, Kusnecov AW, Silverstein SM (2014) Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehavioral Reviews 38:72–93

Article  Google Scholar 

Feng D, Li P, Xiao W, Pei Z, Chen P, Hu M, Yang Z, Li T, Xia Z, Cui H (2023) N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury. J Ethnopharmacol 317:116823

Article  CAS  PubMed  Google Scholar 

Fernandez-Egea E, Vertes PE, Flint SM, Turner L, Mustafa S, Hatton A, Smith KG, Lyons PA, Bullmore ET (2016) Peripheral immune cell populations associated with cognitive deficits and negative symptoms of treatment-resistant schizophrenia. PLoS ONE 11:e0155631

Article  PubMed  PubMed Central  Google Scholar 

Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, Weickert CS (2016) Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry 21:1090–1098

Article  CAS  PubMed  Google Scholar 

Fond G, Godin O, Boyer L, Berna F, Andrianarisoa M, Coulon N, Brunel L, Bulzacka E, Aouizerate B, Capdevielle D, Chereau I, D’Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Schürhoff F, Leboyer M, Andrianarisoa M, Aouizerate B, Bazin N, Berna F, Blanc O, Brunel L, Bulzacka E, Capdevielle D, Chereau-Boudet I, Chesnoy-Servanin G, Danion JM, D’Amato T, Deloge A, Delorme C, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Fluttaz C, Fond G, Fonteneau S, Gabayet F, Giraud-Baro E, Hardy-Bayle MC, Lacelle D, Lançon C, Laouamri H, Leboyer M, Le Gloahec T, Le Strat Y, Llorca PM, Mallet J, Metairie E, Misdrahi D, Offerlin-Meyer I, Passerieux C, Peri P, Pires S, Portalier C, Ramet L, Rey R, Roman C, Sebilleau M, Schandrin A, Schürhoff F, Tessier A, Tronche AM, Urbach M, Vaillant F, Vehier A, Vidailhet P, Vilà E, Yazbek H, Zinetti-Bertschy A, the F-SZG (2019) Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci 269:985–992

Article  CAS  PubMed  Google Scholar 

Galea I (2021) The blood–brain barrier in systemic infection and inflammation. Cell Mol Immunol 18:2489–2501

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gee SH, Shergill SS, Taylor DM (2018) Long-term follow-up of clozapine prescribing. J Psychopharmacol 32:552–558

Article  CAS  PubMed  Google Scholar 

George M, Maheshwari S, Chandran S, Manohar JS, Sathyanarayana Rao TS (2017) Understanding the schizophrenia prodrome. Indian J Psychiatry 59:505–509

PubMed  PubMed Central  Google Scholar 

Gillespie AL, Samanaite R, Mill J, Egerton A, MacCabe JH (2017) Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic

Giridharan VV, Scaini G, Colpo GD, Doifode T, Pinjari OF, Teixeira AL, Petronilho F, Macêdo D, Quevedo J, Barichello T (2020) Clozapine prevents poly (I:C) Induced inflammation by modulating NLRP3 pathway in Microglial cells. Cells 9:577

Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696–1709

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griffiths K, Mellado MR, Chung R, Lally J, McQueen G, Sendt KV, Gill